Olga Golovina

leader researcher
Russian Research Institute of Hematology and Transfusiology
Saint-Petersburg, Saint Petersburg City, Russia

Presentation(s):

• PB0192 - Parameters of thromboelastography and XIIа-dependent fibrinolysis in patients with Ph-negative myeloproliferative neoplasms

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0895 - Coagulation parameters and endothelial dysfunction markers in patients with essential thrombocythemia and polycythemia vera depending on thrombotic history

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0896 - Correlation of coagulation parameters with prognosis of COVID-19.

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0869 - Thrombin generation in acute period of COVID-19

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1461 - Effect of therapy on thrombin generation in patients with polycythemia vera

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1457 - Endothelial dysfunction in patients with polycythemia vera on cytoreductive and / or antiplatelet therapy

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1367 - Microparticle-associated thrombin generation in patients after COVID-19.

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1318 - Platelet functional activity in untreated patients with Ph-negative myeloproliferative neoplasms

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1364 - Prognostic value of blood plasma microparticles for the outcomes of coronavirus infection.

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1449 - The effect of therapy on the coagulation activity of microparticles in patients with polycythemia vera

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT